You are here
Buz Investors Best Biotech Stock 2017 The biotech industry is one of the more lucrative–if volatile–sectors around for heady investors. Forex News 

Amgen Stock: The One Best Biotech Stock Play for 2017

Amgen Stock – the Best Biotech Stock 2017? Buz Investors Best Biotech Stock 2017  The biotech industry is one of the more lucrative–if volatile–sectors around for heady investors. With so much depending on government regulation, competition, and public opinion, there’s a lot of room to make big gains in the biotech industry, and a lot of room to see your money evaporate before you can say “Phase III approval.” That’s why it’s so important to find a solid company with both longevity and strong growth potential; otherwise, you might find…

Read More
Biotechnology Stocks: Tiny Biotech Stock Poised to Surge Market Trends 

Biotechnology Stocks: Tiny Biotech Stock Poised to Surge

Biotechnology Stocks: Tiny Biotech Stock Poised to Surge Biotechnology stocks represent a great opportunity for investors who are fortunate enough to get into the right names at the right time. Amphastar Pharmaceuticals Inc(NASDAQ:AMPH) stock represents the best of both worlds when it comes to a biotechnology stock. The company is both a developer and a gateway for generic drugs. Shortly after breaking out of the triangle, AMPH stock generated a “golden cross” on May 27, 2016. A golden cross is a bullish signal that is produced when a 50-day moving…

Read More
VRX Stock: This Could Be the No. 1 Biotech Stock Market Trends 

VRX Stock: This Could Be the No. 1 Biotech Stock

VRX Stock: This Could Be the No. 1 Biotech Stock Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has gained almost 14% this week on the New York Stock Exchange. a former major Valeant Pharmaceutical shareholder, is suing the company’s former CEO Michael Pearson as well as other former and some current executives in New Jersey. Valeant Pharmaceuticals, with its new CEO Joe Papa (an outsider when it comes to any of the accusations the company is facing), may eventually change its name if the reputation associated with its current brand interferes with…

Read More